RGO x Unitec Venture Talks Biotech with Madiha Derouazi

Register now

What

For this post-summer break Venture Talk, we are delighted to welcome Dr Madiha Derouazi, a scientist and serial biotech entrepreneur with a remarkable journey from academia to biotech innovation.
 
Come and meet a key figure in the biotech startup ecosystem, who co-founded additional ventures and held various leadership roles in the field of vaccines and immunotherapy.In this session, Madiha will share her experience, lessons learned, and candid insights into building science-driven companies.
 
This is a unique opportunity to engage with a founder who has successfully bridged the gap between research and real-world impact!

Who

Entrepreneurs or anyone with a startup idea.

When

September 30, 2025 - 12:15-13:30

Where

SIP, Building G, Room 3H8
Rue des Vieux Grenadiers 10
1205 Geneva
Google Maps

Further Information

Madiha Derouazi - Madiha is an accomplished immunologist and serial entrepreneur. She is the CEO of Switchkine and held before several executive positions including in AC Immune (CSO), Speransa Therapeutics (CEO), AMAL Therapeutics (CEO and founder, acquired in 2019 by Boehringer Ingelheim).

Madiha has a proven track records in company development strategy including progressing early-stage assets to clinical development. She holds a PhD in Cellular Biotechnology from the Swiss Federal Institute of Technology (EPFL) in Lausanne which was followed by postdoc AT CNRS and senior assistant at the University of Geneva, both focusing on tumor immunology and vaccine development.

For any question

UNIGE Startups WhatsApp Group

Genevan entrepreneurs, stay in touch with people who share your interest in entrepreneurship!

Join the UNIGE Startups WhatsApp Group!🎯

You’ll be able to:

  • Share ideas
  • Find potential collaborators and partners
  • Stay informed with important announcements and events

This is not a chat group, but a space for sharing valuable information, opportunities, and updates.

Join the WhatsApp group!

24 Jul 2025

2025

research-grants-office(at)unige.ch
tel:+41 22 379 76 47